invIOs stands for innovative immuno-oncology and is a privately held biotech company based in Vienna, Austria, focused on the discovery and development of innovative cancer immunotherapies.
— Sachs Associates (@SachsAssociates) January 31, 2022
e-Meet @invIOs_com at #Sachs_ELSF
More info @ https://t.co/b7zJA2j8ns pic.twitter.com/xMEGgGxUSH
